Catalyst Pharmaceuticals NASDAQ: CPRX stockholders approved the company’s proposed merger with Angelini Pharma S.p.A. at a special meeting held virtually on July 8, according to remarks from company officials during the meeting.Patrick J. McEnany, chairman of Catalyst’s board of directors, presided over the meeting and said stockholders were asked to vote on three matters described in the company’s definitive proxy statement. The central item was the adoption of the agreement and plan of merger dated May 6, ...